An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade
Theranostics · 2026-07-29 · 16 (15) · 8478-8500
DOI: 10.7150/thno.131237 ↗At a glance
Journal article in Theranostics, published on 2026-07-29. Written by Angelo Corti and 16 co-authors. Institution: Tumor Biology and Vascular Targeting Unit, Comprehensive Cancer Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. Major MEDLINE topics: Integrins, Antigens, Neoplasm, Transforming Growth Factor beta, Immune Checkpoint Inhibitors. The full text is freely available in PubMed Central.
Abstract (original language)
No abstract available.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Tumor Biology and Vascular Targeting Unit, Comprehensive Cancer Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
- Lymphocyte Activation Unit, Division of Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Istituto di Scienze e Tecnologie Chimiche (SCITEC-CNR), National Research Council of Italy, Milan, Italy.
- Translational Biology, In vivo Pharmacology and Analytical Chemistry, Evotec, 195, Route D'Espagne, 31100, Toulouse, France.
- Proteomics and Metabolomics Facility, Center for Omics Sciences, IRCCS San Raffaele, Milan, Italy.
Cite
APA
Corti, A., Gasparri, A. M., Colombo, B., Taiè, G., Sangiovanni, E., Sitia, L., Barreca, V., Schirru, A., Gori, A., Garrigues, L., Chabot, S., Andolfo, A., Ponzoni, M., Mondino, A., Pocaterra, A., Doglioni, C., & Curnis, F. (2026). An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade. Theranostics, 16(15), 8478-8500. https://doi.org/10.7150/thno.131237
Vancouver
Corti A, Gasparri AM, Colombo B, Taiè G, Sangiovanni E, Sitia L, et al. An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade. Theranostics. 2026;16(15):8478-8500. doi:10.7150/thno.131237
BibTeX
@article{Corti2026,
author = {Corti, Angelo and Gasparri, Anna Maria and Colombo, Barbara and Taiè, Giulia and Sangiovanni, Elisa and Sitia, Leopoldo and Barreca, Valeria and Schirru, Alice and Gori, Alessandro and Garrigues, Luc and Chabot, Sophie and Andolfo, Annapaola and Ponzoni, Maurilio and Mondino, Anna and Pocaterra, Arianna and Doglioni, Claudio and Curnis, Flavio},
title = {An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade},
journal = {Theranostics},
year = {2026},
volume = {16},
number = {15},
pages = {8478--8500},
doi = {10.7150/thno.131237}
}
EUVIMED